Andy Karl Arnaud Django Gboka

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Tellimer Ltd. is an independent Great Britain-based frontier market brokerage firm which was founded in 1999 by Peter Bartlett as Exotix Partners LLP through joint venture with ICAP plc. Headquartered in London, the firm specializes in illiquid bonds and loans, equities, structured finance, asset management, research and capital raising in frontier markets. In 2007, private holding company IPGL Ltd. became a significant shareholder in the firm. Tellimer's core competencies are their specialist understanding of illiquid, distressed or undervalued debt and equity, skills in raising structured finance or capital and alternative investments. Through their client base, investor relationships, international presence and research capability, they are able to identify value, provide specialist expertise and advice as well as intermediate buyers and sellers and originate, structure, place or distribute emerging markets products.

Société Générale SA (UK) (Société Générale UK) is the Great Britain-based brokerage division of Societe Generale SA (XP: GLE, ADR: SCGLY) in France. Headquartered in London, Société Générale UK was founded in 1993 and provides broking services.